Rho-kinase contributes to hypoxia/reoxygenation-induced cerebral endothelial dysfunction

Journal of Cardiovascular Pharmacology

Volumn 48, Issue 1, 2006, Pages 814-819

  Xie, Hui ^a,b   Ray, Patricio E ^a   Short, Billie Lou ^a  

^a GEORGE WASHINGTON UNIVERSITY   (United States)

^b CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

Author keywords

Cerebral arteries; Endothelium; Hypoxia reoxygenation; Nitric oxide (NO); Rho kinase

Indexed keywords

3,3 BIS(2 AMINOETHYL) 1 HYDROXY 2 OXOTRIAZENE; 4 (1 AMINOETHYL) N (4 PYRIDYL)CYCLOHEXANECARBOXAMIDE; ACETYLCHOLINE; ARGININE; CHELERYTHRINE; ENDOTHELIAL NITRIC OXIDE SYNTHASE INHIBITOR; N(G) NITROARGININE METHYL ESTER; NITRATE; NITRIC OXIDE; NITRIC OXIDE DONOR; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE INHIBITOR; NITRITE; PROTEIN KINASE C; PROTEIN KINASE C INHIBITOR; RHO KINASE; RHO KINASE INHIBITOR; SUPEROXIDE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTERIAL PRESSURE; ARTERY DIAMETER; ARTICLE; BRAIN ARTERY; BRAIN HYPOXIA; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME SUBSTRATE COMPLEX; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; TISSUE OXYGENATION; VASODILATATION;

ACETYLCHOLINE; ALKALOIDS; AMIDES; ANIMALS; ANOXIA; BENZOPHENANTHRIDINES; CEREBRAL ARTERIES; ENDOTHELIUM, VASCULAR; ENZYME INHIBITORS; INTRACELLULAR SIGNALING PEPTIDES AND PROTEINS; MALE; MUSCLE, SMOOTH, VASCULAR; NG-NITROARGININE METHYL ESTER; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; OXYGEN; PHENANTHRIDINES; PROTEIN-SERINE-THREONINE KINASES; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; SUPEROXIDES; TRIAZENES; VASODILATION; VASODILATOR AGENTS;

EID: 33747751531     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.fjc.0000211797.52905.52     Document Type: Article

References (41)

1. Shimokawa H, Takeshita A. Rho-Kinase is important therapeutic target in cardiovascular medicine. Arterioscler Thromb Vasc Biol. 2005;25:1767-1775.
2. Somlyo AP, Somlyo AV. Signal transduction by G-proteins, Rho-kinase and protein phosphatase to smooth muscle and non-muscle myosin II. J Physiol. 2000;522:177-185.
3. Satoh S, Utsunomiya T, Tsurui K, et al. Pharmacological profile of hydroxy fasudil as a selective Rho-kinase inhibitor on ischemic brain damage. Life Sci. 2001;69:1441-1453.
4. Rikitake Y, Kim HH, Huang Z, et al. Inhibition of Rho-kinase (ROCK) leads to increased cerebral blood flow and stroke protection. Stroke. 2005;36:2251-2257.
5. Rajagopalan S, Kurz S, Münzel T, et al. Angiotensin II mediated hypertension in the rat increases vascular superoxide production via membrane NADH/NADPH oxidase activation: contribution to alterations of vasomotor tone. J Clin Invest. 1996;97:1916-1923.
6. Wang HD, Hope S, Du Y, et al. Paracrine role of adventitial superoxide anion in mediating spontaneous tone of the isolated rat aorta in angiotensin II-induced hypertension. Hypertension. 1999;33:1225-1232.
7. Didion SP, Faraci FM. Angiotensin II produces superoxide-mediated impairment of endothelial function in cerebral arterioles. Stroke. 2003;34:2038-2042.
8. Yan C, Huang A, Wu Z, et al. Increased superoxide leads to decreased flow-induced dilation in resistance arteries of Mn-SOD-deficient mice. Am J Physiol Heart Circ Physiol. 2005;288:H2225-H2231.
9. Jin LM, Ying ZK, Webb RC. Activation of Rho/Rho-kinase signaling pathway by reactive oxygen species in rat aorta. Am J Physiol Heart Circ Physiol. 2004;287:H1495-H1500.
10. Higashi M, Shimokawa H, Hattori T, et al. Long-term inhibition of Rho-kinase suppresses angiotensin II-induced cardiovascular hypertrophy in rats in vivo: effect on endothelial NAD(P)H oxidase system. Circ Res. 2003;93:767-775.
11. Chitaley K, Webb RC. Nitric oxide induces dilation of rat aorta via inhibition of Rho-kinase signaling. Hypertension. 2002;39:438-442.
12. ++ sensitization of contraction in vascular smooth muscle. J Biol Chem. 2000;275:21722-21729.
13. Sawada N, Itoh H, Yamashita J, et al. cGMP-dependent protein kinase phosphorylates and inactivates RhoA. Biochem Biophys Res Commun. 2001;280:798-805.
14. Xie H, Ray PE, Short BL. NF-κB activation plays a role in superoxide-mediated cerebral endothelial dysfunction after hypoxia/ reoxygenation. Stroke. 2005;36:1047-1052.
15. Hiroki J, Shimokawa H, Higashi M, et al. Inflammatory stimuli upregulate Rho-kinase in human coronary vascular smooth muscle cells. J Mol Cell Cardiol. 2004;37:537-546.
16. Uehata M, Ishizaki T, Satoh H, et al. Calcium sensitization of smooth muscle mediated by a Rho-associated protein kinase in hypertension. Nature. 1997;389:990-994.
17. Ishizaki T, Uehata M, Tamechika I, et al. Pharmacological properties of Y-27632, a specific inhibitor of Rho-associated kinases. Mol Pharmacol. 2000;57:976-983.
18. Hrabie JA, Klosie JR, Wink DA. New nitric oxide-releasing zwitterions derived from polyamines. J Org Chem. 1993;58:1472-1476.
19. Morley D, Keefer LK. Nitric oxide/nucleophile complexes: a unique class of nitric oxide-based vasodilators. J Cardiovasc Pharmacol. 1993;22:S3-S9.
20. Halpern W, Osol G. Influence of transmural pressure on myogenic responses of isolated cerebral arteries of the rat. Ann Biomed Eng. 1985;13:287-293.
21. Xie H, Bevan JA. Oxidized low-density lipoprotein enhances myogenic tone in the rabbit posterior cerebral artery through the release of endothelin-1. Stroke. 1999;30:2423-2430.
22. 2 conditions. Can J Physiol Pharmacol. 1994;72:1171-1179.
23. Liu Q. Constriction to hypoxia-reoxygenation in isolated mouse coronary arteries: role of endothelium and superoxide. J Appl Physiol. 1999;87:1392-1396.
24. Chrissobolis S, Sobey CG. Evidence that Rho-kinase activity contributes to cerebral vascular tone in vivo and is enhanced during chronic hypertension: comparison with protein kinase C. Circ Res. 2001;88:774-779.
25. Gonzales RJ, Krause DN, Duckles SP. Testosterone suppresses endothelium-dependent dilation of rat middle cerebral arteries. Am J Physiol Heart Circ Physiol. 2004;286:H552-H560.
26. Rahimian R, Laher I, Dube G, et al. Estrogen and selective estrogen receptor modulator LY117018 enhance release of nitric oxide in rat aorta. J Pharmacol Exp Ther. 1997;283:116-122.
27. Wallis SJ, Martin W. Conditions permitting suppression of stretch-induced and vasoconstrictor tone by basal nitric oxide activity in porcine cerebral artery. Br J Pharmacol. 2000;130:567-574.
28. Ingyinn M, Lee J, Short BL, et al. Venoarterial extracorporeal membrane oxygenation (VA ECMO) impairs basal nitric oxide production in cerebral arteries of newborn lambs. Pediatr Crit Care Med. 2000;1:161-165.
29. Stirone C, Boroujerdi A, Duckles SP, et al. Estrogen receptor activation of phosphoinositide-3 kinase, Akt, and nitric oxide signaling in cerebral blood vessels: rapid and long-term effects. Mol Pharmacol. 2005;67:105-113.
30. Lagaud GJ, Skarsgard PL, Laher I, et al. Heterogeneity of endothelium-dependent vasodilation in pressurized cerebral and small mesenteric resistance arteries of the rat. J Pharmacol Exp Ther. 1999;290:832-839.
31. Yada T, Shimokawa H, Hiramatsu O, et al. Beneficial effect of hydroxyfasudil, a specific Rho-kinase inhibitor, on ischemia/reper-fusion injury in canine coronary microcirculation in vivo. J Am Coll Cardiol. 2005;45:599-607.
32. Teraishi K, Kurata H, Nakajima A, et al. Preventive effect of Y-27632, a selective Rho-kinase inhibitor, on ischemia/reperfusion-induced acute renal failure in rats. Eur J Pharmacol. 2004;505:205-211.
33. Sato M, Tani E, Fujikawa H, et al. Involvement of Rho-kinase-mediated phosphorylation of myosin light chain in enhancement of cerebral vasospasm. Circ Res. 2000;87:195-200.
34. Gokina NI, Park KM, McElroy-Yaggy K, et al. Effects of Rho-kinase inhibition on cerebral artery myogenic tone and reactivity. J Appl Physiol. 2005;98:1940-1948.
35. Takemoto M, Sun J, Hiroki J, et al. Rho-kinase mediates hypoxia-induced downregulation of endothelial nitric oxide synthase. Circulation. 2002;106:57-62.
36. Marrelli SP, Johnson TD, Khorovets A, et al. Altered function of inward rectifier potassium channels in cerebrovascular smooth muscle after ischemia/reperfusion. Stroke. 1998;29:1469-1474.
37. Jones SV. Role of the small GTPase Rho in modulation of the inwardly rectifying potassium channel Kir2.1. Mol Pharmacol. 2003;64:987-993.
38. Anwar KN, Fazal F, Malik AB, et al. RhoA/Rho-associated kinase pathway selectively regulates thrombin-induced intercellular adhesion molecule-1 expression in endothelial cells via activation of I kappa B kinase beta and phosphorylation of RelA/p65. J Immunol. 2004;173:6965-6972.
39. Pluta RM, Rak R, Wink DA, et al. Effects of nitric oxide on reactive oxygen species production and infarction size after brain reperfusion injury. Neurosurgery. 2001;48:884-892.
40. Schluter KD, Weber M, Schraven E, et al. NO donor SIN-1 protects against reoxygenation-induced cardiomyocyte injury by a dual action. Am J Physiol. 1994;267:H1461-H1466.
41. Bolz SS, Vogel L, Sollinger D, et al. Nitric oxide-mediated decrease in calcium sensitivity of resistance arteries is attributable to activation of the myosin light chain phosphatase and antagonized by the RhoA/Rho-kinase pathway. Circulation. 2003;107:3081-3087.